                                                                                                                                   II




                                  113TH CONGRESS
                                     1ST SESSION                            S. 315
                                        To reauthorize and extend the Paul D. Wellstone Muscular Dystrophy
                                        Community Assistance, Research, and Education Amendments of 2008.




                                              IN THE SENATE OF THE UNITED STATES
                                                             FEBRUARY 13, 2013
                                  Ms. KLOBUCHAR (for herself, Mr. WICKER, Mr. SANDERS, Ms. COLLINS, Mr.
                                      MENENDEZ, Mr. ISAKSON, Ms. MIKULSKI, Mr. LEAHY, Mr. LAUTEN-
                                      BERG, and Mr. NELSON) introduced the following bill; which was read
                                      twice and referred to the Committee on Health, Education, Labor, and
                                      Pensions




                                                                            A BILL
                                  To reauthorize and extend the Paul D. Wellstone Muscular
                                     Dystrophy Community Assistance, Research, and Edu-
                                     cation Amendments of 2008.
                                    1              Be it enacted by the Senate and House of Representa-
                                    2 tives of the United States of America in Congress assembled,
                                    3     SECTION 1. SHORT TITLE.
                                    4              This Act may be cited as the ‘‘Paul D. Wellstone
                                    5 Muscular Dystrophy Community Assistance, Research and
                                    6 Education (MD–CARE) Amendments of 2013’’.





                                    1     SEC. 2. INITIATIVE THROUGH THE DIRECTOR OF THE NA- 2
                                    2                             TIONAL INSTITUTES OF HEALTH.
                                    3              Section 404E of the Public Health Service Act (42
                                    4 U.S.C. 283g) is amended—
                                    5                        (1) in subsection (a)(1)—
                                    6                                 (A) by striking ‘‘Muscoskeletal’’ and in-
                                    7                        serting ‘‘Musculoskeletal’’; and
                                    8                                 (B)         by     inserting             ‘‘Becker,           myotonic,
                                    9                        facioscapulohumeral muscular dystrophy (re-
                                  10                         ferred to in this section as ‘FSHD’), Congenital
                                  11                         muscular dystrophy, Limb-girdle muscular dys-
                                  12                         trophy,’’ after ‘‘Duchenne,’’;
                                  13                         (2) in subsection (b)—
                                  14                                  (A) in paragraph (2), by inserting ‘‘cardiac
                                  15                         and pulmonary function,’’ after ‘‘imaging, ge-
                                  16                         netics,’’; and
                                  17                                  (B) in paragraph (3), by inserting ‘‘and
                                  18                         sharing of data’’ after ‘‘regular communica-
                                  19                         tion’’;
                                  20                         (3) in subsection (d)—
                                  21                                  (A) in paragraph (2)—
                                  22                                         (i) in the matter preceding subpara-
                                  23                                  graph (A), by striking ‘‘15’’ and inserting
                                  24
                                                                      ‘‘18’’; and
                                  25                                         (ii) in subparagraph (A), by striking
                                  26                                  ‘‘children with muscular dystrophy, such as
                                              •S 315 IS

                                                                                             3
                                    1                                 the Department of Education’’ and insert-
                                    2                                 ing ‘‘children and adults with muscular
                                    3                                 dystrophy, such as the Department of
                                    4                                 Education, the Social Security Administra-
                                    5                                 tion, the United States Administration for
                                    6                                 Community Living’’; and
                                    7                                 (B) in paragraph (4)(B), by inserting ‘‘,
                                    8                        and shall meet no less than two times per cal-
                                    9                        endar year’’ before the period;
                                  10                         (4) in subsection (e)—
                                  11                                  (A) in paragraph (1)—
                                  12                                         (i) in the matter preceding subpara-
                                  13                                  graph (A), by striking ‘‘through the na-
                                  14                                  tional research institutes’’ and inserting
                                  15                                  ‘‘through the represented Federal agen-
                                  16                                  cies’’; and
                                  17                                         (ii) in subparagraph (A), by striking
                                  18                                  ‘‘and rehabilitative issues, including studies
                                  19                                  of the impact of such diseases in rural and
                                  20                                  underserved communities’’ and inserting
                                  21                                  ‘‘public resources, and rehabilitative issues,
                                  22                                  including studies of the impact of such dis-
                                  23                                  eases in rural and underserved commu-




                                  24                                  nities, health economic studies to dem-
                                  25                                  onstrate the cost-effectiveness of providing


                                              •S 315 IS

                                                                                             4
                                    1                                 independent living resources and support
                                    2                                 to patients with various forms of muscular
                                    3                                 dystrophy, and studies to determine opti-
                                    4                                 mal clinical care interventions for adults
                                    5                                 with various forms of muscular dys-
                                    6                                 trophy’’; and
                                    7                                 (B) in paragraph (2), by adding at the end
                                    8                        the following:
                                    9                                 ‘‘(F) The development of clinical interven-
                                  10                         tions to improve the health of adults with var-
                                  11                         ious forms of muscular dystrophy.’’; and
                                  12                         (5) in subsection (g), by striking ‘‘for the var-
                                  13               ious forms of muscular dystrophy by prioritizing the
                                  14               achievement of the goals related to this topic in the
                                  15               plan under subsection (e)(1)’’ and inserting ‘‘and
                                  16               shall, not later than 6 months after the date of en-
                                  17               actment of the Paul D. Wellstone Muscular Dys-
                                  18               trophy Community Assistance, Research and Edu-
                                  19               cation (MD–CARE) Amendments of 2013, in coordi-
                                  20               nation with appropriate Federal agencies, including
                                  21               relevant offices within the Food and Drug Adminis-
                                  22               tration and supported by the National Institutes of
                                  23               Health and Department of Defense, develop a plan




                                  24               to expedite the evaluation and approval of emerging
                                  25               therapies and personalized medicines that have the


                                              •S 315 IS

                                                                                             5
                                    1              potential to decrease fatal disease progression across
                                    2              the various forms of muscular dystrophy’’.
                                    3     SEC. 3. SURVEILLANCE AND RESEARCH REGARDING MUS-
                                    4                             CULAR DYSTROPHY.
                                    5              Section 317Q of the Public Health Service Act (42
                                    6 U.S.C. 247b–18) is amended—
                                    7                        (1) in the second sentence of subsection (b), by
                                    8              inserting before the period the following: ‘‘and en-
                                    9              sure that the program captures data from different
                                  10               racial and ethnic populations, and that such data
                                  11               are made publicly available to investigators con-
                                  12               ducting public or private research on muscular dys-
                                  13               trophy’’; and
                                  14                         (2) in subsection (c), by adding at the end the
                                  15               following: ‘‘The Secretary shall also foster ongoing
                                  16               engagement and collaboration between the surveil-
                                  17               lance program and centers of excellence.’’.
                                  18      SEC. 4. INFORMATION AND EDUCATION.
                                  19               Section 5(c) of the Muscular Dystrophy Community
                                  20 Assistance, Research and Education Amendments of 2001
                                  21 (42 U.S.C. 247b–19(c)) is amended by adding at the end
                                  22 the following:
                                  23                         ‘‘(4) Update and widely disseminate existing




                                  24               Duchenne-Becker muscular dystrophy care consider-
                                  25               ations for pediatric patients, develop and widely dis-


                                              •S 315 IS

                                                                                             6
                                    1              seminate Duchenne-Becker muscular dystrophy care
                                    2              considerations for adult patients, and develop and
                                    3              widely disseminate acute care considerations for all
                                    4              muscular dystrophy populations. The care consider-
                                    5              ations should build upon existing efforts currently
                                    6              underway               for       congenital               muscular              dystrophy,
                                    7              fascioscapulohumeral muscular dystrophy, limb-gir-
                                    8              dle muscular dystrophy, and myotonic muscular dys-
                                    9              trophy, and incorporate strategies specifically re-
                                  10               sponding to the findings of the national transitions
                                  11               survey of minority, young adult and adult commu-
                                  12               nities of muscular dystrophy patients.’’.
                                              •S 315 IS                                    Æ
